News
HeartBeam announced that it entered into a strategic collaboration with AccurKardia to enhance cardiac monitoring ...
BofA lowered the firm’s price target on Tempus AI (TEM) to $48 from $60 and keeps a Neutral rating on the shares. Sentiment for Life Sciences and Diagnostic Tools and Contract Research ...
Abbott's first-of-a-kind smartphone compatible heart monitor has been approved by for use in the US. Now with the FDA's blessing, the Confirm Rx Insertable Cardiac Monitor (ICM) can be used by US ...
Need a new monitor for your PC? We’ve combed through scores of options to find the best monitors on the market right now. Our picks are the result of hundreds of hours spent testing the latest ...
In that study, GSK is drawing on Tempus' TIME Trial Programme, a just-in-time network of providers that supports patient identification, site activation, and clinical trial enrolment.
The best monitor for MacBook Pro laptops deliver a seamless, Apple-friendly experience and help expand your screen beyond the MBP's 14-inch and 16-inch displays. We've tested out all the best ...
In the modern era, advancements in implantable cardiac monitors are revolutionizing the landscape of cardiac healthcare. These sophisticated devices, designed to continuously track heart activity, are ...
CONTINUOUS monitoring of heart rate recovery (HRR) using wearable ECG technology can identify individuals at higher risk of cardiovascular and metabolic disorders, achieving an 86% accuracy in risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results